Skip to content

Clinical trials

Completed Pulmonary Arterial Hypertension trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Arterial Hypertension Status: Completed Country / region: Israel Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20063
20071
20083
20091
20101
20112
20121
20133
20151
20171
20181
20191
20213
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Actelion8
United Therapeutics7
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA3
Merck Sharp & Dohme LLC2
Bayer1
Daniel Benjamin1
GB002, Inc.1
Lung Biotechnology PBC1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Arterial Hypertension25
Hypertension, Pulmonary8
Hypertension3
Adenoviridae Infections1
Anxiety Disorders1
Arrhythmias, Cardiac1
Autistic Disorder1
Bipolar Disorder1
Bradycardia1
Cardiovascular Diseases1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.